David Paolini, MD
Vascular Surgery · Mesa, AZNPI 1245229004
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,315 of the $9,089 with a category attached, or 80.5%. It is spread thinly across 39 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,374 and has fallen 76.6% since, to $791 in 2025.
Across 182 payments — averaging $49.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$2K
- W. L. Gore & Associates, Inc.$1K
- Philips North America LLC$1K
- Silk Road Medical, Inc.$1K
- Medtronic$538
- Endologix LLC$358
- plus $3K from 33 others
Across 1 payment — averaging $375.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bard Peripheral Vascular, Inc.$375
What the payments were for
- Travel & lodging$1,77420%
- Food & beverage$7,31580%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 27 | $1,883 |
| W. L. Gore & Associates, Inc. | 30 | $1,379 |
| Philips North America LLC | 6 | $1,083 |
| Silk Road Medical, Inc. | 9 | $1,029 |
| Medtronic(2 entities) | 14 | $538 |
| Endologix LLC | 1 | $358 |
| Johnson & Johnson(2 entities) | 25 | $344 |
| Limflow Inc. | 2 | $324 |
| Shockwave Medical, Inc | 4 | $319 |
| Integra Lifesciences Corporation | 3 | $221 |
| Bard Peripheral Vascular, Inc. | 5 | $184 |
| Stryker | 1 | $150 |
| Zimmer Biomet | 1 | $140 |
| Cook Medical LLC | 8 | $135 |
| Kerecis Limited | 1 | $134 |
| Lemaitre Vascular, Inc. | 5 | $100 |
| Penumbra, Inc. | 2 | $95 |
| Boston Scientific | 5 | $84 |
| E.r. Squibb & Sons, L.L.C. | 5 | $62 |
| Abiomed | 2 | $61 |
| Surmodics, Inc. | 2 | $59 |
| Tactile Systems Technology Inc | 3 | $50 |
| Pfizer | 3 | $40 |
| Davol Inc. | 1 | $35 |
| Angiodynamics, Inc. | 1 | $30 |
| KCI USA, Inc. | 1 | $29 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $29 |
| Biocompatibles, Inc. | 2 | $25 |
| Solventum Corporation | 1 | $21 |
| Cvrx, Inc. | 1 | $21 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $18 |
| Misonix Inc | 1 | $17 |
| Getinge USA Sales, LLC | 1 | $16 |
| Livanova USA, Inc. | 1 | $14 |
| Atricure, Inc. | 1 | $14 |
| Biom'up SA | 1 | $14 |
| Biom'up France SAS | 1 | $13 |
| Teleflex LLC | 1 | $12 |
| Artivion, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$1,444
- CT THROMBECTOMY SYSTEM KIT$1,444
- IGT D Peripheral$973
- ENROUTE Transcarotid Neuroprotection System$904
- ENROUTE Transcarotid Stent System$904
- ENHANCE Transcarotid Peripheral Access Kit$904
- ENROUTE 0.014 Guidewire$904
- INTEGRA$464
- Kerecis Omega3 SurgiClose$401
- Ovation$358
- LIMFLOW SYSTEM$324
- EXCLUDER AAA Endoprosthesis$290
- MC3 NAUTILUS(TM) ECMO OXYGENATOR$166
- INTEGRA DERMAL REGENERATION TEMPLATE$155
- PRIMATRIX$155
- ARTIX MT$150
- C3 Delivery System$147
- RIBFIX BLU ADVANTAGE$140
- Kerecis Omega3 GraftGuide$134
- Kerecis Omega3 Marigen$134
How this compares
$9,089 in reported general payments places this provider in the 55th percentile of 105 vascular surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 59 | $52,530 |
| XareltoRivaroxaban | 24 | $22,405 |
| Doxycycline Hyclate | 29 | $494 |
| ClopidogrelClopidogrel Bisulfate | 48 | $429 |
| Gabapentin | 21 | $171 |
| Atorvastatin Calcium | 19 | $76 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $40 | $52,53059 claims |
| Johnson & JohnsonXarelto | $344 | $22,40524 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 105 vascular surgery providers in Arizona.
Other vascular surgery in Mesa
- Hammad AmerMesa$169K
- Xiaoyi LiMesa$16K
- Daniel KrcelicMesa$10K
- Stacey HancockMesa$7K
- Henry TarlianMesa$6K
- Paul RiesenmanMesa$5K
- Venkatesh RamaiahScottsdale$452K
- Jeromy BrinkPhoenix$392K
- Luis LeonPhoenix$185K
- Baljeet UppalSun City$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.